Related Experiment Video
Updated: Mar 13, 2026
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
Published on: July 12, 2021
Focal Seizures in Patients With SCN1A Mutations
Christopher L McDonald1, Russell P Saneto2, Lionel Carmant3
11 Pediatric Neuroscience Center, Seattle, WA, USA.
Insights
Mutations in the SCN1A gene are linked to specific infant and childhood epilepsies. This study highlights key trends and clinical management considerations for pediatric epilepsy associated with SCN1A gene mutations.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- The SCN1A gene is associated with the development of various epilepsy types.
- Recent studies link SCN1A mutations to specific epilepsies manifesting in infancy or early childhood.
Purpose of the Study:
- To investigate the clinical course and pathology of pediatric epilepsy linked to SCN1A gene mutations.
- To identify key trends and clinical management strategies for SCN1A-related epilepsy in children.
Main Methods:
- Retrospective analysis of 20 pediatric patients with focal seizures and confirmed SCN1A genetic mutations.
- Examination of the time course and pathological features of the disorder.
Main Results:
- Identified significant trends in the disorder's progression within the studied cohort.
- Highlighted critical aspects of clinical practice for managing patients with SCN1A mutations.
Conclusions:
- SCN1A gene mutations are a significant factor in pediatric epilepsy.
- Understanding disease trends and clinical considerations is crucial for effective patient management.
Abstract:
The SCN1A gene has been implicated in the etiology of various forms of epilepsy. New research has linked this gene to specific types of epilepsy, all of which present in infancy or early childhood. This study examines the time course and pathology of pediatric patients who have a mutation in the SCN1A gene in order to open a discussion regarding the key trends of this form of epilepsy as well as important clinical considerations in management for patients who present with symptoms relating to the SCN1A mutations. We retrospectively examined 20 patients who presented to the clinic with focal seizures, as well as were positive for an SCN1A genetic mutation. Despite the small sample size, we were able to find important trends in the time course of the disorder as well as important areas of clinical practice that must be taken into consideration for these patients.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
11:54Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
Related Concept Videos
01:13Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...